Clinical study on splenic radiation dose constraints. Preoperative PD-1 inhibitor (tislelizumab) plus SOX for locally advanced gastric or gastro-oesophageal junction cancer: Results from a single-arm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results